Analgesics

Competition from generics is limiting sales of OTC analgesics. In Spain the same active ingredient in analgesics can be bought as an OTC product or as a reimbursed product. This distorts sales of OTC analgesics in Spain as a fair percentage of ...

Demand for topical analgesics/anaesthetic ranges continues to rise, leading to these products achieving the highest value sales growth in 2019. An increasing number of consumers with strong health consciousness seek products that are used externally,...

The up-scheduling of all OTC products containing codeine, including many combination products - analgesics in 2018 led to severe sales declines during that year. 2019 saw further declines in the category, although on a much smaller scale. With ...

Analgesics continued to record healthy current value growth in 2019. Among the drivers behind this growth are the increasingly hectic lifestyles being led by local consumers, particularly in cities. The young workforce is career-focused, particularly...

Denmark has an ageing population and the proportion of the country’s population aged 65 and over increased steadily over the course of the review period. This is because chronic mild to moderate pain remains prevalent among the older population. The ...

Topical analgesics/ anaesthetic continued to enjoy increasing consumer preference for treating chronic pain in 2019. Systemic analgesics have long been regarded as more effective for the relief of chronic pain, but in recent years some topical ...

Whilst sales during the flu season and emergency-use purchases remain the main revenue sources for analgesics, environmental issues also influence demand for analgesics. With air pollution becoming more severe, and extremely cold winters in the ...

Analgesics is one of the most popular OTC categories among Slovak consumers given widespread use of such products for symptom suppression of common ailments like flu, general body pains, back, joint, muscle and tooth ache. In addition, consumers are ...

Weak purchasing power following the devaluation of the local currency in 2016 led to Azerbaijani consumers becoming more rational in their purchasing decisions towards the end of the review period. Consequently, categories including products ...

In January 2019, the Drug Regulatory Authority of Pakistan (DRAP) notified a 15% increase in the retail price of medicines (9% on lifesaving drugs). The price rise came as a result of the weakening of the Pakistan rupee against the dollar, partly in ...

In 2019, paediatric analgesics continued growing albeit from a low base in Georgia. Consumption was low mainly due to poor awareness, however this has gradually changed, and paediatric analgesics outpaced the value sales growth of overall analgesics ...

Analgesics continued to see good sales over 2019 thanks to the 2018 ban on selling antibiotics without a prescription. As a result, Saudi consumers continued to use more analgesics whenever they experience pain whether it is due to headaches, fever ...

Analgesics is the second largest category within OTC in Greece in value terms. Nevertheless, stronger sales are limited by the low retail price of leading brand Depon, together with the widespread use of brands that do not have an OTC status for pain...

Paediatric ibuprofen was the most dynamic analgesics category in current value growth terms in 2019, and looks set to retain this status over the forecast period. The category will continue to benefit from increasing consumer appreciation for the ...

Analgesics is a large and diverse category in Romania and demand is spread relatively evenly over numerous categories, sustained by a high level of self-medication among consumers. Thus, positive growth over the forecast period is set to be based on ...

Following another sharp drop in analgesics sales in current value terms in 2018, the category performance continued to be negative in 2019, albeit with sales falling at a slower rate than a year earlier. The repercussions from the ban on OTC sales of...

The first line of medicine for common ailments such as pain, fever, and flu symptoms in the United Arab Emirates continued to be analgesics at the end of the review period. It is highly common to find analgesics such as Panadol or Brufen in a ...

In 2019, analgesics registered double-digit current value growth, with further progress expected over the forecast period. However, rising prices was the main factor boosting value sales, as volume sales declined in most categories. Paediatric ...

Ibuprofen has gained ground against aspirin and acetaminophen, commonly known as paracetamol, for more than 12 years, and today its per capita consumption in value terms is very high compared to that of the other two categories as its unit price is ...

Analgesics in Singapore continued to experience stable demand in 2019, as local consumers became increasingly confident in self-medicating, particularly for general pain relief such as headaches, and aches and pains. Rising healthcare costs combined ...